(Q54061823)

24 May 2018

title

Influence of insulin resistance on total renin level in normotensive women with polycystic ovary syndrome. (English)

1 reference

24 May 2018

polycystic ovary syndrome

main subject

1 reference

1 reference

1 reference

1 reference

Hacihanefioglu B

1

1 reference

24 May 2018

Seyisoglu H

2

1 reference

24 May 2018

Karsidag K

3

1 reference

24 May 2018

Elter K

4

1 reference

24 May 2018

Aksu F

5

1 reference

24 May 2018

Yilmaz T

6

1 reference

24 May 2018

Gurol AO

7

1 reference

24 May 2018

language of work or name

English

0 references

publication date

1 February 2000

1 reference

24 May 2018

published in

Fertility and Sterility

1 reference

24 May 2018

volume

73

1 reference

24 May 2018

issue

2

1 reference

24 May 2018

page(s)

261-265

1 reference

24 May 2018

Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900497-5

Insulin Resistance in Secondary Hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900497-5

The role of the renin-angiotensin system in insulin sensitivity in normotensive subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900497-5

Serum total renin is elevated in women with polycystic ovarian syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900497-5

Clinical assessment of body hair growth in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900497-5

The tyrosine kinase domain of the insulin receptor gene is normal in women with hyperinsulinaemia and polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900497-5

The significance of polycystic-appearing ovaries versus normal-appearing ovaries in patients with polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900497-5

Continuous infusion of glucose with model assessment: measurement of insulin resistance and beta-cell function in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900497-5

Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900497-5

Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900497-5

Total renin after gonadotropin stimulation in polycystic ovarian disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900497-5

Sequential changes in plasma luteinizing hormone and plasma prorenin during the menstrual cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900497-5

Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900497-5

Skeletal muscle blood flow. A possible link between insulin resistance and blood pressure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900497-5

Effects of angiotensin II on insulin sensitivity: a placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900497-5

10.1016/S0015-0282(99)00497-5

7 January 2021

Identifiers

DOI

1 reference

24 May 2018

1 reference

24 May 2018